Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06699810 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

StatusRecruiting
PhasePhase 4
Started2025-01-23
View on ClinicalTrials.gov ↗

Amendment history

2026-06-12
Study Status, Contacts/Locations v3
Trial status changed: Active, Not Recruiting → Recruiting
Primary completion pushed: 2026-06 → 2027-01
Completion pushed: 2026-06 → 2027-01
Study sitesdetails revised at 2 of 2 sites
2026-04-02
Recruiting→Active, Not Recruiting Study Identification, Study Status, Oversight, Contacts/Locations v2
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2025-12→2026-06
Completion date2025-12→2026-06
Study sitesdetails revised at 2 of 2 sites
2025-01-24
Study Status, Oversight v1
Start dateestimated 2024-11→confirmed 2025-01-23
2024-11-19
Original filing
Emory University
371 trials monitored
See 23 trials at risk
Diabetes
4,247 trials monitored
See 176 trials at risk
Type 1 Diabetes
844 trials monitored
See 34 trials at risk
The goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a mathematical model of KPDM pathogenesis and remission.
Trial Details
NCT Number NCT06699810
Lead Sponsor Emory University
Conditions Ketosis Prone Diabetes
Enrollment 12 participants
Start Date 2025-01-23
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-15